[1] |
Neifert SN, Chapman EK, Martini ML, et al. Aneurysmal subarachnoid hemorrhage: the last decade[J]. Transl Stroke Res, 2021, 12(3): 428-446.
|
[2] |
高文文,王凤鹿,蒋小兵, 等. 扰动系数在脑出血患者脑水肿监测治疗中的作用[J]. 中华脑科疾病与康复杂志(电子版), 2020, 10(5): 305-308.
|
[3] |
林洁,何明莲,邹永杰, 等. 无创脑水肿动态监测仪对急性脑损伤诊断价值的Meta分析[J]. 中华脑科疾病与康复杂志(电子版), 2020, 10(3): 132-138.
|
[4] |
中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组,中华医学会神经病学分会神经血管介入协作组. 中国蛛网膜下腔出血诊治指南2019[J]. 中华神经科杂志, 2019, 52(12): 1006-1021.
|
[5] |
Fuentes AM, Stone McGuire L, Amin-Hanjani S. Sex differences in cerebral aneurysms and subarachnoid hemorrhage[J]. Stroke, 2022, 53(2): 624-633.
|
[6] |
Hua X, Gray A, Wolstenholme J, et al. Survival, dependency, and health-related quality of life in patients with ruptured intracranial aneurysm: 10-year follow-up of the united kingdom cohort of the international subarachnoid aneurysm trial[J]. Neurosurgery, 2021, 88(2): 252-260.
|
[7] |
Xia F, Keep RF, Ye F, et al. The fate of erythrocytes after cerebral hemorrhage[J]. Transl Stroke Res, 2022, 13(5): 655-664.
|
[8] |
Claassen J, Park S. Spontaneous subarachnoid haemorrhage[J]. Lancet, 2022, 400(10355): 846-862.
|
[9] |
中华人民共和国国家卫生健康委员会. 中国动脉瘤性蛛网膜下腔出血诊疗指导规范(一)[J]. 全科医学临床与教育, 2022, 20(2): 100-102.
|
[10] |
Hayman EG, Wessell A, Gerzanich V, et al. Mechanisms of global cerebral edema formation in aneurysmal subarachnoid hemorrhage[J]. Neurocrit Care, 2017, 26(2): 301-310.
|
[11] |
Li Y, Wu P, Bihl JC, et al. Underlying mechanisms and potential therapeutic molecular targets in blood-brain barrier disruption after subarachnoid hemorrhage[J]. Curr Neuropharmacol, 2020, 18(12): 1168-1179.
|
[12] |
高文文. 无创颅内压监测在神经外科疾病中的应用前景[J]. 中国临床神经外科杂志, 2020, 25(1): 54-56.
|
[13] |
陈慧,王健,董为伟, 等. 无创脑电阻抗测定动态监测蛛网膜下腔出血后脑水肿的临床研究[J].第三军医大学学报, 2010, 32(15): 1656-1659.
|
[14] |
杜玉民,谭冬,袁宇. 无创脑水肿动态监护仪在动脉瘤自发性蛛网膜下腔出血患者术后脑水肿监测中的应用[J]. 国际神经病学神经外科学杂志, 2022, 49(1): 66-67.
|
[15] |
中华医学会神经外科学分会小儿学组,中华医学会神经外科学分会神经重症协作组,《甘露醇治疗颅内压增高中国专家共识》编写委员会. 甘露醇治疗颅内压增高中国专家共识[J]. 中华医学杂志, 2019, 99(23): 1763-1766.
|